{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:54:29Z","timestamp":1765727669981},"reference-count":24,"publisher":"Elsevier BV","issue":"27-28","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.vaccine.2006.03.088","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T17:42:46Z","timestamp":1145468566000},"page":"5637-5644","source":"Crossref","is-referenced-by-count":34,"title":["Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity"],"prefix":"10.1016","volume":"24","author":[{"given":"Sharif","family":"Uddin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansel R.","family":"Haeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalind","family":"Warrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Balmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Arkwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.03.088_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1473-3099(01)00170-0","article-title":"Estimates of world-wide distributions of child deaths from acute respiratory infections","volume":"2","author":"Williams","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2006.03.088_bib2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(99)00122-X","article-title":"The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known","volume":"17","author":"Fedson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.03.088_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00130832-200312000-00006","article-title":"Primary immunodeficiencies associated with pneumococcal disease","volume":"3","author":"Picard","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2006.03.088_bib4","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.vaccine.2003.11.038","article-title":"Pneumococcal vaccines: an update on current strategies","volume":"22","author":"Bogaert","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.03.088_bib5","series-title":"Bacterial Pathogenesis: A Molecular Approach","first-page":"279","article-title":"Streptococcus pneumoniae","author":"Salyers","year":"2002"},{"key":"10.1016\/j.vaccine.2006.03.088_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00001432-200306000-00006","article-title":"Immunity to Streptococcus pneumoniae: factors affecting production and efficacy","volume":"16","author":"Casal","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2006.03.088_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)01280-6","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2006.03.088_bib8","first-page":"127","article-title":"IgG2 subclass restriction of antibody to pneumococcal polysaccharides","volume":"63","author":"Barrett","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2006.03.088_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CDLI.10.2.202-207.2003","article-title":"Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults","volume":"10","author":"Schauer","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.03.088_bib10","first-page":"289","article-title":"Assessment of functional antibody responses","volume":"87","author":"Borrow","year":"2003","journal-title":"Method Mol Med"},{"key":"10.1016\/j.vaccine.2006.03.088_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.03.088_bib12","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2006.03.088_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/adc.87.1.18","article-title":"Should the new pneumococcal vaccine be used in high-risk children?","volume":"87","author":"Finn","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2006.03.088_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2249.1993.tb07959.x","article-title":"The acquisition of anti-pneumococcal capsular polysaccharide, Haemophilus influenzae type B and tetanus toxoid antibodies with age in the UK","volume":"93","author":"Hazlewood","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2006.03.088_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jim.2004.11.006","article-title":"Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes","volume":"296","author":"Lal","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2006.03.088_bib16","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations of the use in infants","volume":"1","author":"J\u00f3dar","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.03.088_bib17","first-page":"118","article-title":"Primary immunodeficiency diseases. Report of an IUIS Scientific Committee","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2006.03.088_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2006.03.088_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.20052036","article-title":"T-independent type II immune responses generate memory B cells","volume":"203","author":"Obukhanych","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2006.03.088_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-3083.1992.tb01628.x","article-title":"Specific IgG subclass antibody levels and phagocytosis of serotype 14 pneumococcus following immunisation","volume":"11","author":"Kaniuk","year":"1992","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2006.03.088_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2249.1999.01077.x","article-title":"Contribution of serotype-specific IgG concentrations, IgG subclass and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae","volume":"118","author":"Anttila","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2006.03.088_bib22","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/323648","article-title":"Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant","volume":"184","author":"Wuorimaa","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.03.088_bib23","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/420849","article-title":"Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria\/tetanus-conjugated vaccine: a randomized controlled trial","volume":"189","author":"Lucero","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.03.088_bib24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/CDLI.11.6.1100-1104.2004","article-title":"Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults","volume":"11","author":"Southern","year":"2004","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06004166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06004166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T23:40:08Z","timestamp":1586821208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06004166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":24,"journal-issue":{"issue":"27-28","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0264410X06004166"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.03.088","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}